57.86
price down icon0.86%   -0.5107
 
loading

Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten

pulisher
Sep 27, 2026

Form 144 Royalty Pharma PLC For: 27 September By Investing.com - Investing.com Nigeria

Sep 27, 2026
pulisher
Sep 26, 2026

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - Eastern Progress

Sep 26, 2026
pulisher
Sep 26, 2026

Royalty Pharma (NASDAQ:RPRX) Rating Lowered to Buy at Wall Street Zen - MarketBeat

Sep 26, 2026
pulisher
Sep 25, 2026

Form 4 Royalty Pharma Plc For: 25 September - Investing.com India

Sep 25, 2026
pulisher
Sep 25, 2026

Form 4 Royalty Pharma Plc For: 25 September By Investing.com - Investing.com Canada

Sep 25, 2026
pulisher
Sep 25, 2026

Royalty Pharma EVP Christopher Hite sells $5.85m in shares By Investing.com - Investing.com Australia

Sep 25, 2026
pulisher
Sep 25, 2026

Royalty Pharma EVP Christopher Hite sells $5.85m in shares - Investing.com

Sep 25, 2026
pulisher
Sep 25, 2026

Royalty Pharma plc (RPRX) stock price, news, quote and history - Yahoo Finance Singapore

Sep 25, 2026
pulisher
Sep 25, 2026

Royalty Pharma Eyes AI, China Growth While Navigating Biopharma Policy Shifts - MarketBeat

Sep 25, 2026
pulisher
Sep 24, 2026

Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines? - The Motley Fool

Sep 24, 2026
pulisher
Sep 24, 2026

Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $5,853,000.00 in Stock - MarketBeat

Sep 24, 2026
pulisher
Sep 24, 2026

Royalty Pharma plc (RPRX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 24, 2026
pulisher
Sep 24, 2026

RPHC5237354 Bond Profile: Coupon and Redemption - TradingView

Sep 24, 2026
pulisher
Sep 23, 2026

Royalty Pharma PLC (RPD) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026
pulisher
Sep 23, 2026

Royalty Pharma PLC (RPD) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026
pulisher
Sep 23, 2026

Royalty Pharma PLC (RPD) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026
pulisher
Sep 23, 2026

Royalty Pharma PLC (RPD) Q3 2023 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026
pulisher
Sep 23, 2026

Royalty Pharma PLC (RPD) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026
pulisher
Sep 23, 2026

Royalty Pharma PLC (RPD) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026
pulisher
Sep 23, 2026

Royalty Pharma PLC (RPD) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026
pulisher
Sep 23, 2026

RPRX: Strategic AI, scalable deal models, and China expansion drive robust, diversified growth - TradingView

Sep 23, 2026
pulisher
Sep 23, 2026

Royalty Pharma PLC (RPD) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026
pulisher
Sep 23, 2026

Royalty Pharma PLC (RPD) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026
pulisher
Sep 23, 2026

Royalty Pharma at Bank of America Global Healthcare Conference: growth even with policy risks - Investing.com Nigeria

Sep 23, 2026
pulisher
Sep 23, 2026

Royalty Pharma (RPRX) Stock Looks Richly Priced After Its 136% Run - Yahoo Finance

Sep 23, 2026
pulisher
Sep 23, 2026

Price-Driven Insight from (RPRX) for Rule-Based Strategy - Stock Traders Daily

Sep 23, 2026
pulisher
Sep 23, 2026

Royalty Pharma (RPRX) Could Be 10% Undervalued As Conference Spotlight Returns - Yahoo Finance

Sep 23, 2026
pulisher
Sep 23, 2026

Royalty Pharma PLC (RPD) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks

Sep 23, 2026
pulisher
Sep 23, 2026

Andra AP fonden Lowers Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat

Sep 23, 2026
pulisher
Sep 22, 2026

Royalty Pharma PLC (RPD) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks

Sep 22, 2026
pulisher
Sep 22, 2026

Royalty Pharma (RPRX) holder plans new sale after selling 350,000 shares - Stock Titan

Sep 22, 2026
pulisher
Sep 22, 2026

Royalty Pharma PLC (RPD) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks

Sep 22, 2026
pulisher
Sep 21, 2026

Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 11.5% Potential Upside in the Biotech Royalty Space - DirectorsTalk Interviews

Sep 21, 2026
pulisher
Sep 21, 2026

NewEdge Advisors LLC Raises Stock Position in Royalty Pharma PLC $RPRX - MarketBeat

Sep 21, 2026
pulisher
Sep 19, 2026

Royalty Pharma PLC $RPRX Shares Sold by Corient Private Wealth LP - MarketBeat

Sep 19, 2026
pulisher
Sep 18, 2026

Could Royalty Pharma’s (NASDAQ:RPRX) Story Be Changing Fast? - Kalkine Media

Sep 18, 2026
pulisher
Sep 18, 2026

Royalty Pharma PLC (NASDAQ:RPRX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Sep 18, 2026
pulisher
Sep 15, 2026

Is Royalty Pharma (RPRX) Below Fair Value After The Pelacarsen Trial Miss? - simplywall.st

Sep 15, 2026
pulisher
Sep 15, 2026

Royalty Pharma announces $7.5 million gift to Blood Cancer United to expand Therapy Acceleration Program - GlobeNewswire

Sep 15, 2026
pulisher
Sep 15, 2026

A $7.5 million gift will help develop new blood cancer treatments - Stock Titan

Sep 15, 2026
pulisher
Sep 14, 2026

Royalty Pharma at Morgan Stanley conference: growth broadens beyond royalties By Investing.com - Investing.com UK

Sep 14, 2026
pulisher
Sep 14, 2026

WINTON GROUP Ltd Invests $1.28 Million in Royalty Pharma PLC $RPRX - MarketBeat

Sep 14, 2026
pulisher
Sep 13, 2026

Royalty Pharma PLC $RPRX Shares Sold by National Pension Service - marketbeat.com

Sep 13, 2026
pulisher
Sep 13, 2026

Tidal Investments LLC Has $6.63 Million Holdings in Royalty Pharma PLC $RPRX - MarketBeat

Sep 13, 2026
pulisher
Sep 12, 2026

(RPRX) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Sep 12, 2026
pulisher
Sep 12, 2026

California State Teachers Retirement System Increases Holdings in Royalty Pharma PLC $RPRX - MarketBeat

Sep 12, 2026
pulisher
Sep 12, 2026

Wall Street Zen Upgrades Royalty Pharma (NASDAQ:RPRX) to Strong-Buy - MarketBeat

Sep 12, 2026
pulisher
Sep 11, 2026

Engineers Gate Manager LP Grows Position in Royalty Pharma PLC $RPRX - MarketBeat

Sep 11, 2026
pulisher
Sep 10, 2026

Royalty Pharma (RPRX): Can Downside Protection Offset Pelacarsen’s Phase 3 Failure? - Yahoo Finance

Sep 10, 2026
pulisher
Sep 10, 2026

Squarepoint Ops LLC Decreases Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat

Sep 10, 2026
pulisher
Sep 10, 2026

Royalty Pharma to present at Morgan Stanley global healthcare investor conference - Bitget

Sep 10, 2026
$35.88
price down icon 3.04%
$115.52
price down icon 2.08%
$253.57
price down icon 0.93%
ONC ONC
$361.40
price down icon 1.66%
$200.81
price down icon 0.50%
Kapitalisierung:     |  Volumen (24h):